A Qualitative Case Study in Uzbekistan: Digital Pedagogical Creativity among Teacher Candidates at a Creativity-Centred Programme
Granite · 01.05.2026 · 10 (2)
DOI: 10.57064/2164/27300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Granite, online erschienen am 01.05.2026. Verfasst von Anar Hamdan AlRuwaie.
Abstract (Originalsprache)
This study introduces a new mixed-methods methodological approach to improve the English-speaking proficiency of EFL university students in Kuwait. Although the English language has de facto official status in Kuwait (Dashti, 2015 p#), numerous studies (Alraban et al., 2016; Mahsain, 2014) have noted that English language proficiency in the country remains low. There is evidence to suggest, however, that AI-based technology may be beginning to have an impact on informal English language education in Kuwait (Sabih, 2024). This study therefore aims to present a methodological approach using the AI-based language learning platform ImmerseMe to answer the following research question: Can AI technology can be used to increase the English-speaking proficiency of EFL students in Kuwait? This study intends to contribute to a growing body of research on the effectiveness of AI learning in the EFL field, especially against the backdrop of the wide-reaching reforms taking place in the Gulf region.
Zitieren
APA
AlRuwaie, A. H. (2026). A Qualitative Case Study in Uzbekistan: Digital Pedagogical Creativity among Teacher Candidates at a Creativity-Centred Programme. Granite, 10(2). https://doi.org/10.57064/2164/27300
Vancouver
AlRuwaie AH. A Qualitative Case Study in Uzbekistan: Digital Pedagogical Creativity among Teacher Candidates at a Creativity-Centred Programme. Granite. 2026;10(2). doi:10.57064/2164/27300
BibTeX
@article{AlRuwaie2026,
author = {AlRuwaie, Anar Hamdan},
title = {A Qualitative Case Study in Uzbekistan: Digital Pedagogical Creativity among Teacher Candidates at a Creativity-Centred Programme},
journal = {Granite},
year = {2026},
volume = {10},
number = {2},
doi = {10.57064/2164/27300}
}
EUVIMED